K. Selmaj

发表

Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis

K. Selmaj, M. GRUDZIECKA PYREK, K. Selmaj, 2022, Frontiers in Neurology.

Multiple sclerosis

R. Maini, K. Rockett, G. Perkin, 1986, Neurology.

P 1 Effect of ocrelizumab on magnetic resonance imaging markers of neurodegeneration in patients with relapsing multiple sclerosis – analysis of the phase III, double-blind, double-dummy, interferon beta-1a- controlled OPERA I and OPERA II studies

G. Comi, D. Arnold, A. Bar-Or, 2017, Clinical Neurophysiology.

T lymphocyte-derived demyelinating activity in multiple sclerosis patients in relapse.

G. Perkin, R. Alam, F. Rose, 1987, Journal of neurology, neurosurgery, and psychiatry.

Optical coherence tomography in multiple sclerosis

J. Nawrocki, M. Siger, M. Siger, 2008, Journal of Neurology.

Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.

L. Kappos, C. Polman, P. Calabresi, 2012, Archives of neurology.

Alemtuzumab improves visual outcomes in treatment-naïve patients with relapsing–/INS;remitting multiple sclerosis (RRMS): Analysis from the phase 3 CARE-MS I study

D. Arnold, H. Hartung, E. Havrdová, 2013, Journal of the Neurological Sciences.

Studies on lymphokine‐mediated demyelination in organotypic rat cerebellum in culture

E. Kida, M. Maszewska, R. Alam, 1986, Acta neurologica Scandinavica.

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.

D. Arnold, F. Zipp, E. Havrdová, 2014, Journal of neurology.